Publication related online materials
Model 1:In the general GBM population
Model 2:In patients treated by RT/TMZ (MGMT methylation status unavailable)
Model 3: In patients with partial or total resection and treated by RT/TMZ (MGMT methylation status available)
Kaplan Meier survival estimates for the main prognostic factors - Calibration of the nomograms
More on nomograms and survival models validation
- Sauerbrei W, Schumacher M. A bootstrap resampling procedure for model building: application to the Cox regression model. Stat Med 1992; 11: 2093–109.
- Harrell FE Jr, Lee KL, Mark DB. Tutorial in biostatistics. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361–87.
More on clinical prognostic factors for Glioblastoma
- Curran WJ, Scott CB, Horton J, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993; 85: 704–10.
- Scott CB, Scarantino C, Urtasun R, et al. Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys 1998; 40: 51–55.
- Kreth FW, Berlis A, Spiropoulou V, et al. The role of tumor resection in the treatment of glioblastoma multiforme in adults. Cancer 1999; 86: 2117–23.
- Jeremic B, Milicic B, Grujicic D, Dagovic A, Aleksandrovic J. Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach. J Cancer Res Clin Oncol 2003; 129: 477–84.
- Lutterbach J, Sauerbrei W, Guttenberger R. Multivariate analysis of prognostic factors in patients with glioblastoma. Strahlenther Onkol 2003; 179: 8–15.
- Lamborn KR, Chang SM, Prados MD. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol 2004; 6: 227–35.
- Stelzer KJ, Sauvé KI, Spence AM, Gri. n TW, Berger MS. Corpus callosum involvment as a prognostic factor for patients with high-grade astrocytoma. Int J Radiat Oncol Biol Phys 1997; 38: 27–30.
- Gamburg ES, Regine WF, Patchell RA, Strottmann JM, Mohiuddin M, Young AB. The prognostic signi. cance of midline shift at presentation on survival in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2000; 48: 1359–62.
- Jeremic B, Milicic B, Grujicic D, Dagovic A, Aleksandrovic J, Nikolic N. Clinical prognostic factors in patients treated with malignant glioma treated with combined modality approach. Am J Clin Oncol 2004; 27: 195–204.
- Buckner JC. Factors influencing survival in high grade gliomas. Semin Oncol 2003; 30 (6 suppl 19): 10–14.
- Brown PD, Buckner JC, O’Fallon JR, et al. Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma. Int J Radiat Oncol Biol Phys 2004; 59: 117–25.
- Brown PD, Balmann KV, Rummans TA, et al. Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. J Neurooncol 2006; 76: 283–91.
- Hegi ME, Diserens A-C, Gorlia T, et al. MGMT gene silencing and bene. t from temozolomide in glioblastoma. N Engl J Med 2005; 352: 997–1003.
- Hegi ME, Stupp R. Correlative studies in neuro-oncology trials: should they in. uence treatment? Curr Oncol Rep 2006; 8: 54–57.
- Mirimanoff. RO, Gorlia T, Mason W, et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: a recursive partitioning analysis of EORTC 26981/22981-NCI.CE3 phase III
randomized trial. J Clin Oncol 2006; 24: 2563–69. - Hohwieler SM, Freidberg SH, Heatley GJ, Lo TC. Glucocorticoid dependency as a prognostic factor in radiotherapy for cerebral gliomas. Acta Oncol 1989; 28: 51–55.
- Stenning S, Freedman LS, Bleehen NM. Prognostic factors for high grade malignant glioma: development of a prognostic index. J Neurooncol 1990; 9: 47–55.
No comments:
Post a Comment